Market Challenges And Opportunities

Global Calcium Pantothenate Market– Key Drivers

Increasing awareness regarding health issues is expected to drive the market growth over the forecast period.

Increasing awareness regarding health issues is expected to drive the global calcium pantothenate market growth over the forecast period. For instance, in September 2022, Vitamin Angels India, healthcare organization and United Nations International Children's Emergency Fund India for Poshan Maah announced the partnership. This partnership is in line with the Poshan Maah campaign by the Government of India, the goal is to implement a comprehensive, unified outreach and awareness programme to enhance nutritional content, delivery, outreach, and outcomes with a renewed focus on fostering health, wellness, and immunity to disease and undernutrition. During this campaign, Vitamin Angel partners have hosted 160 activities on nutrition related awareness and action across the country, reaching over 100,000 people. These include awareness campaigns, other stakeholders on pre-natal care and malnutrition, administering Vitamin A and Albendazole supplements for children, community theatre and plays, mass nutrition oath, workshops on balanced diet and more.

Moreover, in May 2022, Central University of Punjab, Bathinda (CUPB), and All India Institute of Medical Sciences, Bathinda, government hospital, announced the collaboration, and launched a joint community outreach programme series to raise awareness about Vitamin D deficiency and improve public health.

Rising prevalence of paranoia, depression, and memory loss is propelling the demand for the calcium pantothenate is expected to drive the market growth over the forecast period.

Rising prevalence of paranoia, depression, and memory loss is propelling the demand for the calcium pantothenate is expected to drive the global calcium pantothenate market growth over the forecast period. For instance, in May 2022, according to the data published by the Center for Disease Control and Prevention, paranoid personality disorder is observed to be more common in men than in women and prevalence of the paranoid condition was found to be up to 4.4% of the population in the North America in the year 2021.

Furthermore, according to the data published by the National Centre for Biotechnology Information, in January 2021, it was estimated that 21.0 million adults in the U.S. had at least one major depressive disorder in the year 2020, among which 8.4% were adult citizen of the U.S. In 2020, an estimated 14.8 million U.S. adults aged 18 or older had at least one major depressive episode with severe impairment in the past year. This number represented 6.0% of all the U.S. adults. Moreover, according to the data published by the World Health Organization, in September 2022, it was found that more than 7% of the adults globally are diagnosed with depression half yearly in year 2022.

Global Calcium Pantothenate Market: Restraint

The major factors that hinder growth of the global calcium pantothenate market include less awareness regarding health benefits associated with calcium pantothenic acid in the emerging economies such as majority of African countries.

Global Calcium Pantothenate Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global calcium pantothenate market, owing to the decrease in research and development activities for the calcium pantothenate containing drugs and vitamin injections/ supplements. For instance, according to the data published by the National Center for Biotechnology Information, in October 2020, the government of all the countries imposed lockdown which made difficult to make available the proper resource for carrying out research and development activities. The transmission and distancing issues have caused most non-COVID clinical research to suspended, causing a reduction in recruitment of research subjects and delay data entry in clinical trial database. Global regulatory authorities including the European Medicines Agency (EMA), Food and Drug Administration, and Medicines and Healthcare products Regulatory Agency had promptly released several guidance documents for drug Sponsors since the start of the pandemic, all with one primary goal in mind – the safety of research subjects and patients. These documents have provided critical input on several issues related to study progression during the pandemic, including COVID-19-specific risk mitigation. The urgent clinical trial activities such as drugs and vaccines for COVID – 19 were kept on priority during the COVID - 19 pandemic. Hence, the research and development activities for the drugs containing calcium pantothenate were slowed down during the COVID-19 pandemic and had negative effect on the global calcium pantothenate market.